Interestingly, Carvalho et al. supported increased GC-peripheral sensitivity in T2D patients, due to lower Dex concentration needed to inhibit LPS-induced IL-6 in whole blood cells of T2D patients, as compared to controls [127]. Here, IL6 is linked to type 2 diabetes mellitus.